Bio-Rad Laboratories

BIO.B · NYSE

$379.50+$15.35 (+4.22%)TodayMarket closed ·
No price history for this range.

Latest news

  • Press releaseBusiness Wire

    Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026

  • Press releaseBusiness Wire

    Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum

  • Press releaseBusiness Wire

    Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference

  • Press releaseBusiness Wire

    Bio-Rad Reports Second-Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.